![Karolina Vilval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karolina Vilval
Algemeen Adviseur bij
SEDANA MEDICAL AB
Profiel
Karolina Vilval currently works at Oncopeptides Incentive AB, as Director and Sedana Medical AB, as General Counsel from 2022.
Ms. Vilval also formerly worked at Gilead Sciences Sweden AB, as Associate Director-Legal from 2019 to 2020, Biovitrum AB, as Head-Legal Affairs, Oncopeptides AB, as General Counsel from 2020 to 2022, and Swedish Orphan Biovitrum AB, as Head-Legal Affairs from 2005 to 2019.
Ms. Vilval received her graduate degree from the University of Stockholm.
Actieve functies van Karolina Vilval
| Bedrijven | Functie | Begin |
|---|---|---|
| SEDANA MEDICAL AB | Algemeen Adviseur | 01-08-2022 |
Oncopeptides Incentive AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Karolina Vilval
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOPEPTIDES AB | Algemeen Adviseur | 01-08-2022 |
Gilead Sciences Sweden AB | Algemeen Adviseur | 01-03-2020 |
| SWEDISH ORPHAN BIOVITRUM AB | Algemeen Adviseur | 01-05-2019 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Algemeen Adviseur | - |
Opleiding van Karolina Vilval
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
64
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Gilead Sciences Sweden AB | |
Sedana Medical AB
 Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Oncopeptides Incentive AB |
Kies MarketScreener 
